Literature DB >> 7822146

The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity.

R Klein1, Q Wang, B E Klein, S E Moss, S M Meuer.   

Abstract

PURPOSE: To investigate the relationship of age-related maculopathy, cataract, and glaucoma to visual acuity in the population-based Beaver Dam Eye Study.
METHODS: A cross-sectional, population-based study was performed in people 43 through 86 years of age residing in Beaver Dam, Wisconsin, who were identified between 1987 and 1988 and examined (n = 4926) between 1988 and 1990. Of those who participated, 99.4% were white. Visual acuity was measured (n = 4886) using a modification of the Early Treatment Diabetic Retinopathy Study protocol. Stereoscopic color fundus photographs and slit lamp and retroillumination photographs of the lens were graded in a masked fashion using standardized protocols to determine the presence of age-related maculopathy and central cataract.
RESULTS: Fifty-seven percent of those who were legally blind had late age-related maculopathy in both eyes. The frequency of visual acuity of 20/200 or worse was not significantly different in eyes with exudative macular degeneration (48%) than in eyes with pure geographic atrophy (42%). While controlling for other factors (age, central cataract, and glaucoma) in participants with both gradable age-related maculopathy and visual acuity measurable in at least one eye (n = 4716), investigators found that each of the early age-related maculopathy lesions was associated with a decrease in visual acuity of approximately two letters or fewer when compared to eyes without these lesions. Late age-related maculopathy was associated with a decrease of approximately seven lines of letters read correctly.
CONCLUSION: These data demonstrate that exudative macular degeneration and pure geographic atrophy are the most important causes of legal blindness in this population and that early age-related maculopathy, central cataract, and glaucoma had a small effect on visual acuity.

Entities:  

Mesh:

Year:  1995        PMID: 7822146

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  98 in total

Review 1.  Macular pigment and age related macular degeneration.

Authors:  S Beatty; M Boulton; D Henson; H H Koh; I J Murray
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

Authors:  James H Schick; Sudha K Iyengar; Barbara E Klein; Ronald Klein; Karlie Reading; Rachel Liptak; Christopher Millard; Kristine E Lee; Sandra C Tomany; Emily L Moore; Bonnie A Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-04-24       Impact factor: 11.025

Review 3.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 4.  Intrinsic optical signal imaging of retinal physiology: a review.

Authors:  Xincheng Yao; Benquan Wang
Journal:  J Biomed Opt       Date:  2015-09       Impact factor: 3.170

5.  Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress.

Authors:  Vera L Bonilha; Brent A Bell; Mary E Rayborn; Ivy S Samuels; Anna King; Joe G Hollyfield; Chengsong Xie; Huaibin Cai
Journal:  Free Radic Biol Med       Date:  2017-01-11       Impact factor: 7.376

6.  The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.

Authors:  J T Flynn; G Woodruff; J R Thompson; F Hiscox; W Feuer; J Schiffman; A Corona; L K Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1999

7.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

8.  Use of prescribed optical devices in age-related macular degeneration.

Authors:  Dawn K Decarlo; Gerald McGwin; Karen Searcey; Liyan Gao; Marsha Snow; Lynne Stevens; Cynthia Owsley
Journal:  Optom Vis Sci       Date:  2012-09       Impact factor: 1.973

9.  Assessing reading performance in the periphery with a Bayesian adaptive approach: The qReading method.

Authors:  Timothy G Shepard; Fang Hou; Peter J Bex; Luis A Lesmes; Zhong-Lin Lu; Deyue Yu
Journal:  J Vis       Date:  2019-05-01       Impact factor: 2.240

10.  [Treatment of recurrent neovascular age-related macular degeneration with ranibizumab according to the PrONTO scheme].

Authors:  A Wolf; L Reznicek; J Muhr; M Ulbig; A Kampik; C Haritoglou
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.